Contact
searchSearch
HMP Global

Advertisement

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Cardiovascular Topic Center

Featured Article

Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
Cutting Through Cost Barriers for Heart Failure Medications
03/02/2023
In the latest installment of Talking Therapeutics, Dr Jennings provides a brief history of heart failure medications and discusses the cost effectiveness of quadruple, triple, and double therapy regimens.
In the latest installment of Talking Therapeutics, Dr Jennings provides a brief history of heart failure medications and discusses the cost effectiveness of quadruple, triple, and double therapy regimens.
In the latest installment of...
03/02/2023
Pharmacy Learning Network
From Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
ACC Updates Part 2
06/01/2021
Last week’s edition of Talking Therapeutics highlighted several new and exciting studies related to heart failure drug therapies. This week we tackle three more pivotal trials from this year’s exciting conference.
Last week’s edition of Talking Therapeutics highlighted several new and exciting studies related to heart failure drug therapies. This week we tackle three more pivotal trials from this year’s exciting conference.
Last week’s edition of Talking...
06/01/2021
Pharmacy Learning Network
From Pharmacy Learning Network
Headshot of Mark Munger, PharmD
Commentary
An Update on Heart Failure: World-Wide Burden, Rural Versus Urban Adults, Ethnic Disparities, and Remote Monitoring
06/01/2021
Mark Munger, PharmD, provides up-to-date information on heart failure across the world, related mortality in rural versus urban adults, ethnic disparities in US outcomes, and potential innovations of heart failure care.
Mark Munger, PharmD, provides up-to-date information on heart failure across the world, related mortality in rural versus urban adults, ethnic disparities in US outcomes, and potential innovations of heart failure care.
Mark Munger, PharmD, provides...
06/01/2021
Pharmacy Learning Network
From Pharmacy Learning Network
News
Multidisciplinary Intervention Has No Significant Effect on Heart Failure Readmissions
05/21/2021
A multidisciplinary educational approach to reduce 30-day heart failure readmissions failed to have a significant impact—although readmission rates for patients in both the intervention group and the control group were below national norms.
A multidisciplinary educational approach to reduce 30-day heart failure readmissions failed to have a significant impact—although readmission rates for patients in both the intervention group and the control group were below national norms.
A multidisciplinary educational...
05/21/2021
Pharmacy Learning Network
From Pharmacy Learning Network
Heart Failure Treatment Insight From ACC.2021
Talking Therapeutics
Heart Failure Treatment Insight From ACC.2021
05/19/2021
In this week's installment of Talking Therapeutics, Dr Jennings offers a breakdown on the latest heart failure therapy data, which was recently presented at the American College of Cardiology's annual meeting.
In this week's installment of Talking Therapeutics, Dr Jennings offers a breakdown on the latest heart failure therapy data, which was recently presented at the American College of Cardiology's annual meeting.
In this week's installment of...
05/19/2021
Pharmacy Learning Network
From Pharmacy Learning Network
Hypertension, Hyperlipidemia for Developing and Sustaining Atrial Fibrillation
Commentary
Hypertension, Hyperlipidemia for Developing and Sustaining Atrial Fibrillation
05/04/2021
“Goal-directed use of antihypertensives and statin drugs appear to be effective strategies to reduce atrial fibrillation incidence, morbidity, and mortality,” says Mark Munger, PharmD.
“Goal-directed use of antihypertensives and statin drugs appear to be effective strategies to reduce atrial fibrillation incidence, morbidity, and mortality,” says Mark Munger, PharmD.
“Goal-directed use of...
05/04/2021
Pharmacy Learning Network
From Pharmacy Learning Network
V is for Victory in Heart Failure
Talking Therapeutics
V is for Victory in Heart Failure
04/28/2021
In this week’s issue of Talking Therapeutics, Dr Jennings explores the science and promise of a recently approved novel medication for patients with HFrEF.
In this week’s issue of Talking Therapeutics, Dr Jennings explores the science and promise of a recently approved novel medication for patients with HFrEF.
In this week’s issue of Talking...
04/28/2021
Pharmacy Learning Network
From Pharmacy Learning Network
Targeting Inflammation to Treat Coronary Artery Disease
Talking Therapeutics
Targeting Inflammation to Treat Coronary Artery Disease
04/20/2021
Dr Jennings reviews evidence supporting colchicine use to further reduce residual disease burden in coronary artery disease but highlights why pharmacists need to keep several things in mind when dispensing colchicine to ensure that patients...
Dr Jennings reviews evidence supporting colchicine use to further reduce residual disease burden in coronary artery disease but highlights why pharmacists need to keep several things in mind when dispensing colchicine to ensure that patients...
Dr Jennings reviews evidence...
04/20/2021
Pharmacy Learning Network
From Pharmacy Learning Network
How Do We Achieve Optimal Population Cardiovascular Health?
Commentary
How Do We Achieve Optimal Population Cardiovascular Health?
02/10/2021
Mark Munger, PharmD, professor, Pharmacotherapy and Internal Medicine, University of Utah, discusses the declining rate of cardiovascular health across the world, and highlights what pharmacists can do in order to help support the 2020 goals...
Mark Munger, PharmD, professor, Pharmacotherapy and Internal Medicine, University of Utah, discusses the declining rate of cardiovascular health across the world, and highlights what pharmacists can do in order to help support the 2020 goals...
Mark Munger, PharmD, professor,...
02/10/2021
Pharmacy Learning Network
From Pharmacy Learning Network
Update on Hypertension Epidemiology and Treatment for 2021
Commentary
Update on Hypertension Epidemiology and Treatment for 2021
02/01/2021
Mark Munger, PharmD, discusses recent hypertension research and explains why treatment is important for intensive blood pressure control.
Mark Munger, PharmD, discusses recent hypertension research and explains why treatment is important for intensive blood pressure control.
Mark Munger, PharmD, discusses...
02/01/2021
Pharmacy Learning Network
From Pharmacy Learning Network
News
Cost-Effectiveness of Implantable Loop Recorder Monitoring After Stroke in Line Wth Other Therapies
12/06/2020
For detecting occult atrial fibrillation in patients with cryptogenic stroke, 3-year implantable loop recorder monitoring has a cost per quality-adjusted life-year gained in the range of other publicly funded therapies
For detecting occult atrial fibrillation in patients with cryptogenic stroke, 3-year implantable loop recorder monitoring has a cost per quality-adjusted life-year gained in the range of other publicly funded therapies
For detecting occult atrial...
12/06/2020
First Report Managed Care
From First Report Managed Care

Newsfeed

News
Multidisciplinary Intervention Has No Significant Effect on Heart Failure Readmissions
05/21/2021
A multidisciplinary educational approach to reduce 30-day heart failure readmissions failed to have a significant impact—although readmission rates for patients in both the intervention group and the control group were below national norms.
A multidisciplinary educational approach to reduce 30-day heart failure readmissions failed to have a significant impact—although readmission rates for patients in both the intervention group and the control group were below national norms.
A multidisciplinary educational...
05/21/2021
Pharmacy Learning Network
News
Cost-Effectiveness of Implantable Loop Recorder Monitoring After Stroke in Line Wth Other Therapies
12/06/2020
For detecting occult atrial fibrillation in patients with cryptogenic stroke, 3-year implantable loop recorder monitoring has a cost per quality-adjusted life-year gained in the range of other publicly funded therapies
For detecting occult atrial fibrillation in patients with cryptogenic stroke, 3-year implantable loop recorder monitoring has a cost per quality-adjusted life-year gained in the range of other publicly funded therapies
For detecting occult atrial...
12/06/2020
First Report Managed Care
News
Postacute Care Spending by Hospital Varies Widely After Cardiac Surgery
12/02/2020
“At the hospital-level, postacute care spending was modestly correlated across procedures and payers,” researchers reported. “Spending associated with readmissions, emergency department visits, and outpatient facility care was significantly...
“At the hospital-level, postacute care spending was modestly correlated across procedures and payers,” researchers reported. “Spending associated with readmissions, emergency department visits, and outpatient facility care was significantly...
“At the hospital-level,...
12/02/2020
First Report Managed Care
News
Increased Health Care Utilization, Expenses in Patients With Tricuspid Regurgitation, Heart Failure
11/19/2020
In patients with tricuspid regurgitation, comorbid right-sided heart disease, other valve disease, or heart failure increase health care utilization, according to a study published online in the Journal of Comparative Effectiveness Research.
In patients with tricuspid regurgitation, comorbid right-sided heart disease, other valve disease, or heart failure increase health care utilization, according to a study published online in the Journal of Comparative Effectiveness Research.
In patients with tricuspid...
11/19/2020
First Report Managed Care
News
Value-Based Payments for Cardiovascular Care Yielding Mixed Results
11/12/2020
Researchers recently conducted a review that examined nationwide value-based payment reforms and analyzed how they relate to cardiovascular care, and explain what is expected to come in the future for cardiovascular value-based policies.
Researchers recently conducted a review that examined nationwide value-based payment reforms and analyzed how they relate to cardiovascular care, and explain what is expected to come in the future for cardiovascular value-based policies.
Researchers recently conducted a...
11/12/2020
First Report Managed Care
News
Rate of Opioid Use Disorder in Patients Undergoing Heart Surgery Triples
11/06/2020
"The prevalence of OUD among cardiac surgical patients has steeply increased over the past decade," explained researchers. "Although the presence of OUD was not associated with excess mortality at index hospitalization, it was predictive of...
"The prevalence of OUD among cardiac surgical patients has steeply increased over the past decade," explained researchers. "Although the presence of OUD was not associated with excess mortality at index hospitalization, it was predictive of...
"The prevalence of OUD among...
11/06/2020
First Report Managed Care
News
Preemptive Pharmacogenomic Panel Testing Cost-Effective for Cardiovascular Disease Management
10/26/2020
“Given its potential for long-term cost-effectiveness as documented in our study, health-care payers might consider rolling out preemptive pharmacogenomic panel testing in a system-wide manner with efforts from multiple expertise areas,”...
“Given its potential for long-term cost-effectiveness as documented in our study, health-care payers might consider rolling out preemptive pharmacogenomic panel testing in a system-wide manner with efforts from multiple expertise areas,”...
“Given its potential for...
10/26/2020
First Report Managed Care
News
More Industry Payments at Decreased Amounts Going to Cardiac Electrophysiologists
10/15/2020
The number of industry payments to cardiac electrophysiologists in the United States appears to be growing, although average payment amounts are decreasing, according to a study published online in Journal of Cardiovascular Electrophysiology.
The number of industry payments to cardiac electrophysiologists in the United States appears to be growing, although average payment amounts are decreasing, according to a study published online in Journal of Cardiovascular Electrophysiology.
The number of industry payments...
10/15/2020
First Report Managed Care
News
Utilization Patterns Identified Among Young Adults With Congenital Heart Defects
10/09/2020
Researchers recently analyzed health care utilization patterns and costs associated with adolescents and young adults with congenital heart defects.
Researchers recently analyzed health care utilization patterns and costs associated with adolescents and young adults with congenital heart defects.
Researchers recently analyzed...
10/09/2020
First Report Managed Care
News
Statin Discontinuation Low Among Older Veterans Near End of Life
08/31/2020
A JAGS study recently examined resident and facility factors that could potentially predict statin discontinuation after nursing home admission in veterans with limited life expectancy or advanced dementia taking statins for secondary...
A JAGS study recently examined resident and facility factors that could potentially predict statin discontinuation after nursing home admission in veterans with limited life expectancy or advanced dementia taking statins for secondary...
A JAGS study recently examined...
08/31/2020
Annals of Long-Term Care
News
Increased Scrutiny of Prior Authorization: Are Payers Fully to Blame, and Can AI Improve the Process?
04/05/2024
The increased scrutiny of prior authorization, highlighted by media reports and government actions, prompts debate over payer responsibility while exploring the potential for AI to enhance the process.
The increased scrutiny of prior authorization, highlighted by media reports and government actions, prompts debate over payer responsibility while exploring the potential for AI to enhance the process.
The increased scrutiny of prior...
04/05/2024
First Report Managed Care
News
PhRMA Maps Provide State-by-State Look at 340B Drug Program
04/05/2024
An interactive map made available by the Pharmaceutical Research and Manufacturers of America (PhRMA), a drugmaker advocacy group, shares state-specific data on the 340B Drug Pricing Program. The federal program, initially created over 30...
An interactive map made available by the Pharmaceutical Research and Manufacturers of America (PhRMA), a drugmaker advocacy group, shares state-specific data on the 340B Drug Pricing Program. The federal program, initially created over 30...
An interactive map made...
04/05/2024
First Report Managed Care
News
FTC and HHS Launch Joint Inquiry into Generic Drug Shortages: Seeking Public Input on GPOs and Wholesalers
02/16/2024
In a news release published on February 14, 2024, the US Department of Health and Human Services (HHS) issued a "Request for Information" in collaboration with the Federal Trade Commission (FTC). This request aims to gain insight into how...
In a news release published on February 14, 2024, the US Department of Health and Human Services (HHS) issued a "Request for Information" in collaboration with the Federal Trade Commission (FTC). This request aims to gain insight into how...
In a news release published on...
02/16/2024
First Report Managed Care
News
Medicare Drug Price Negotiations and Anticipated Ripple Effects
02/15/2024
The arrival of the Inflation Reduction Act has ushered in a new era of drug price regulation, giving the Centers for Medicare & Medicaid Services (CMS) the ability to negotiate directly with companies that make some of the costliest drugs...
The arrival of the Inflation Reduction Act has ushered in a new era of drug price regulation, giving the Centers for Medicare & Medicaid Services (CMS) the ability to negotiate directly with companies that make some of the costliest drugs...
The arrival of the Inflation...
02/15/2024
First Report Managed Care
News
Injectable PrEP Overall Acceptable, Preferred for HIV Prevention
07/15/2023
“Given overall acceptability, injectable PrEP should be included as part of a menu of prevention options, allowing end-users to select the modality that suits their preferences, needs and lifestyle,” researchers advised.
“Given overall acceptability, injectable PrEP should be included as part of a menu of prevention options, allowing end-users to select the modality that suits their preferences, needs and lifestyle,” researchers advised.
“Given overall acceptability,...
07/15/2023
First Report Managed Care
News
First Gene Therapy for Severe Hemophilia A Is Approved
06/29/2023
This approval comes after a safety and effectiveness trial showed that the treatment improved participants’ annualized bleeding rate after 3 years.
This approval comes after a safety and effectiveness trial showed that the treatment improved participants’ annualized bleeding rate after 3 years.
This approval comes after a...
06/29/2023
Population Health
News
Low Rate of Social Determinants of Health Z Codes in Adults With Hypertension
06/26/2023
Researchers examined the presence and use of ICD-10-CM social determinants of health (SDOH)-related Z codes among adults with hypertension and found differences in documentation and medical expenditures.
Researchers examined the presence and use of ICD-10-CM social determinants of health (SDOH)-related Z codes among adults with hypertension and found differences in documentation and medical expenditures.
Researchers examined the...
06/26/2023
First Report Managed Care
News
CDC Data Shows Link Between High Costs and Prescription Nonadherence in Adults
06/21/2023
In 2021, medication nonadherence among adults was associated with costs, gender, disability status, insurance coverage, and other characteristics.
In 2021, medication nonadherence among adults was associated with costs, gender, disability status, insurance coverage, and other characteristics.
In 2021, medication nonadherence...
06/21/2023
First Report Managed Care
News
Blood Pressure Injections Recalled
05/26/2023
Several thousand products containing phenylephrine and norepinephrine were recalled due to a lack of sterility assurance.
Several thousand products containing phenylephrine and norepinephrine were recalled due to a lack of sterility assurance.
Several thousand products...
05/26/2023
Pharmacy Learning Network
News
Astral SteriTech Recalls 5 Injections Manufactured for 4 US Clients
05/26/2023
The recalls, designated Class II by the US Food and Drug Administration, impact a variety of antibiotic injections.
The recalls, designated Class II by the US Food and Drug Administration, impact a variety of antibiotic injections.
The recalls, designated Class II...
05/26/2023
Pharmacy Learning Network

Advertisement

Insights

Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
Cutting Through Cost Barriers for Heart Failure Medications
03/02/2023
In the latest installment of Talking Therapeutics, Dr Jennings provides a brief history of heart failure medications and discusses the cost effectiveness of quadruple, triple, and double therapy regimens.
In the latest installment of Talking Therapeutics, Dr Jennings provides a brief history of heart failure medications and discusses the cost effectiveness of quadruple, triple, and double therapy regimens.
In the latest installment of...
03/02/2023
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
ACC Updates Part 2
06/01/2021
Last week’s edition of Talking Therapeutics highlighted several new and exciting studies related to heart failure drug therapies. This week we tackle three more pivotal trials from this year’s exciting conference.
Last week’s edition of Talking Therapeutics highlighted several new and exciting studies related to heart failure drug therapies. This week we tackle three more pivotal trials from this year’s exciting conference.
Last week’s edition of Talking...
06/01/2021
Pharmacy Learning Network
Headshot of Mark Munger, PharmD
Commentary
An Update on Heart Failure: World-Wide Burden, Rural Versus Urban Adults, Ethnic Disparities, and Remote Monitoring
06/01/2021
Mark Munger, PharmD, provides up-to-date information on heart failure across the world, related mortality in rural versus urban adults, ethnic disparities in US outcomes, and potential innovations of heart failure care.
Mark Munger, PharmD, provides up-to-date information on heart failure across the world, related mortality in rural versus urban adults, ethnic disparities in US outcomes, and potential innovations of heart failure care.
Mark Munger, PharmD, provides...
06/01/2021
Pharmacy Learning Network
Heart Failure Treatment Insight From ACC.2021
Talking Therapeutics
Heart Failure Treatment Insight From ACC.2021
05/19/2021
In this week's installment of Talking Therapeutics, Dr Jennings offers a breakdown on the latest heart failure therapy data, which was recently presented at the American College of Cardiology's annual meeting.
In this week's installment of Talking Therapeutics, Dr Jennings offers a breakdown on the latest heart failure therapy data, which was recently presented at the American College of Cardiology's annual meeting.
In this week's installment of...
05/19/2021
Pharmacy Learning Network
Hypertension, Hyperlipidemia for Developing and Sustaining Atrial Fibrillation
Commentary
Hypertension, Hyperlipidemia for Developing and Sustaining Atrial Fibrillation
05/04/2021
“Goal-directed use of antihypertensives and statin drugs appear to be effective strategies to reduce atrial fibrillation incidence, morbidity, and mortality,” says Mark Munger, PharmD.
“Goal-directed use of antihypertensives and statin drugs appear to be effective strategies to reduce atrial fibrillation incidence, morbidity, and mortality,” says Mark Munger, PharmD.
“Goal-directed use of...
05/04/2021
Pharmacy Learning Network
V is for Victory in Heart Failure
Talking Therapeutics
V is for Victory in Heart Failure
04/28/2021
In this week’s issue of Talking Therapeutics, Dr Jennings explores the science and promise of a recently approved novel medication for patients with HFrEF.
In this week’s issue of Talking Therapeutics, Dr Jennings explores the science and promise of a recently approved novel medication for patients with HFrEF.
In this week’s issue of Talking...
04/28/2021
Pharmacy Learning Network
Targeting Inflammation to Treat Coronary Artery Disease
Talking Therapeutics
Targeting Inflammation to Treat Coronary Artery Disease
04/20/2021
Dr Jennings reviews evidence supporting colchicine use to further reduce residual disease burden in coronary artery disease but highlights why pharmacists need to keep several things in mind when dispensing colchicine to ensure that patients...
Dr Jennings reviews evidence supporting colchicine use to further reduce residual disease burden in coronary artery disease but highlights why pharmacists need to keep several things in mind when dispensing colchicine to ensure that patients...
Dr Jennings reviews evidence...
04/20/2021
Pharmacy Learning Network
How Do We Achieve Optimal Population Cardiovascular Health?
Commentary
How Do We Achieve Optimal Population Cardiovascular Health?
02/10/2021
Mark Munger, PharmD, professor, Pharmacotherapy and Internal Medicine, University of Utah, discusses the declining rate of cardiovascular health across the world, and highlights what pharmacists can do in order to help support the 2020 goals...
Mark Munger, PharmD, professor, Pharmacotherapy and Internal Medicine, University of Utah, discusses the declining rate of cardiovascular health across the world, and highlights what pharmacists can do in order to help support the 2020 goals...
Mark Munger, PharmD, professor,...
02/10/2021
Pharmacy Learning Network
Update on Hypertension Epidemiology and Treatment for 2021
Commentary
Update on Hypertension Epidemiology and Treatment for 2021
02/01/2021
Mark Munger, PharmD, discusses recent hypertension research and explains why treatment is important for intensive blood pressure control.
Mark Munger, PharmD, discusses recent hypertension research and explains why treatment is important for intensive blood pressure control.
Mark Munger, PharmD, discusses...
02/01/2021
Pharmacy Learning Network
Identifying the Important Role Pharmacists Play Among Patients Delaying PCP Care During the Pandemic
Videos
Identifying the Important Role Pharmacists Play Among Patients Delaying PCP Care During the Pandemic
11/10/2020
Andrea Russo, MD, director, Electrophysiology and Arrhythmia Services, Cooper Hospital, discusses why there have been delays among patients making primary care visits, along with the impact this has on diagnosis, and she provides tips for...
Andrea Russo, MD, director, Electrophysiology and Arrhythmia Services, Cooper Hospital, discusses why there have been delays among patients making primary care visits, along with the impact this has on diagnosis, and she provides tips for...
Andrea Russo, MD, director,...
11/10/2020
Pharmacy Learning Network

Interactive Features

Quiz
Mortality Rates Lowered Among NH Residents Receiving Statins as Secondary Prevention
03/10/2020
According to study findings, older adults receiving statins after acute myocardial infarction experienced reduced 1-year mortality by what percent?
According to study findings, older adults receiving statins after acute myocardial infarction experienced reduced 1-year mortality by what percent?
According to study findings,...
03/10/2020
Annals of Long-Term Care
Quiz
Adherence Rates Among Patients With AF Who Began Anticoagulation Therapy
02/20/2020
Among those who receive oral anticoagulation therapy, researchers were curious about the following question: “What are the longitudinal patterns of adherence to treatment with warfarin and direct oral anticoagulants among patients with atrial...
Among those who receive oral anticoagulation therapy, researchers were curious about the following question: “What are the longitudinal patterns of adherence to treatment with warfarin and direct oral anticoagulants among patients with atrial...
Among those who receive oral...
02/20/2020
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

What's Trending?

News Connection
Association of Outcomes with Time to Transfer among Trauma Patients
05/13/2011
Trauma systems are designed to achieve the best outcomes for injured patients by establishing triage procedures to assign patients to appropriate levels of care, defining patterns for transport both prehospital and interhospital, and...
Trauma systems are designed to achieve the best outcomes for injured patients by establishing triage procedures to assign patients to appropriate levels of care, defining patterns for transport both prehospital and interhospital, and...
Trauma systems are designed to...
05/13/2011
First Report Managed Care
News
Patient Values May Not Always Align With Choices for End-of-Life Care
10/27/2016
Patients and families state that they value comfort, having time with family and death not being prolonged, but these values often don't align with the treatment they expect at the end of life, according to a new Canadian study.
Patients and families state that they value comfort, having time with family and death not being prolonged, but these values often don't align with the treatment they expect at the end of life, according to a new Canadian study.
Patients and families state that...
10/27/2016
Annals of Long-Term Care
News
FDA head and company CEOs cheer bumper haul of new drugs
01/31/2013
01/31/2013
First Report Managed Care
News Connection
CMS Proposed Rule Cuts 340B Payments
08/30/2017
The Centers for Medicare & Medicaid Services (CMS) announced a proposed rule to cut Agency payments to hospitals under the program. 
The Centers for Medicare & Medicaid Services (CMS) announced a proposed rule to cut Agency payments to hospitals under the program. 
The Centers for Medicare &...
08/30/2017
First Report Managed Care
News
FDA Approves First Treatment For Rare Autoimmune Disease
12/13/2017
The FDA has approved a drug for the treatment of adults with an autoimmune disease. 
The FDA has approved a drug for the treatment of adults with an autoimmune disease. 
The FDA has approved a drug...
12/13/2017
Pharmacy Learning Network

Advertisement

Stay Informed—Sign up today!

Population Health Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement